Filing Details
- Accession Number:
- 0001388658-21-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-21 06:03:31
- Reporting Period:
- 2021-01-17
- Accepted Time:
- 2021-01-21 06:03:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670676 | A David Vort | C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-17 | 12,940 | $0.00 | 28,542 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-01-17 | 6,416 | $250.57 | 22,126 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-01-19 | 2,118 | $35.25 | 24,244 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-19 | 2,882 | $63.95 | 27,126 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-19 | 1,085 | $249.95 | 26,041 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-19 | 1,180 | $250.78 | 24,861 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-19 | 1,778 | $251.95 | 23,083 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-19 | 907 | $252.62 | 22,176 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-19 | 50 | $253.57 | 22,126 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-19 | 2,118 | $0.00 | 2,118 | $35.25 |
| Common Stock | Common Stock | Disposition | 2021-01-19 | 2,882 | $0.00 | 2,882 | $63.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,059 | 2020-12-01 | 2027-02-16 | No | 4 | M | Direct |
| 12,218 | 2019-03-01 | 2028-02-27 | No | 4 | M | Direct |
Footnotes
- Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance restricted stock units (PSUs) granted to the Reporting Person on June 19, 2020.
- Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the issuance of shares pursuant to PSUs granted to the Reporting Person on June 19, 2020.
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
- This transaction was executed in multiple trades at prices ranging from $249.32 to $250.19 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple trades at prices ranging from $250.32 to $251.27 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple trades at prices ranging from $251.335 to $252.27 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple trades at prices ranging from $252.34 to $253.24 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This option, originally granted for 25,400 shares, of which 24,341 shares have been exercised, vested as to 1/4 of the shares on March 1, 2018 and as to 1/36 of the remaining shares each month thereafter.
- This option, originally granted for 15,200 shares, of which 2,882 shares have been exercised, vested as to 1/4 of the shares on March 1, 2019 and as to 1/36 of the remaining shares each month thereafter.
Billionaire Hedge Funds
